Asymptomatic mitral and aortic valve disease is seen in half of the patients taking 'Phen-Fen'

被引：15

作者：

Griffen, L

Anchors, M

机构：

来源：

ARCHIVES OF INTERNAL MEDICINE | 1998年 / 158卷 / 01期

关键词：

D O I：

10.1001/archinte.158.1.102

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：102 / 102

页数：1

共 5 条

[1] Appetite-suppressant drugs and the risk of primary pulmonary hypertension [J].

Abenhaim, L ;

Moride, Y ;

Brenot, F ;

Rich, S ;

Benichou, J ;

Kurz, X ;

Higenbottam, T ;

Oakley, C ;

Wouters, E ;

Aubier, M ;

Simonneau, G ;

Begaud, B .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (09) :609-616

[2]

ANCHORS JM, 1997, ARCH INTERN MED, V157, P1270

[3]

ANCHORS JM, 1997, SAFER THAN PHEN FEN

[4] Valvular heart disease associated with fenfluramine-phentermine [J].

Connolly, HM ;

Crary, JL ;

McGoon, MD ;

Hensrud, DD ;

Edwards, BS ;

Edwards, WD ;

Schaff, HV .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (09) :581-588

[5] LONG-TERM WEIGHT CONTROL - THE NATIONAL-HEART-LUNG-AND-BLOOD-INSTITUTE FUNDED MULTIMODAL INTERVENTION STUDY - INTRODUCTION [J].

WEINTRAUB, M .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (05) :581-585

← 1 →